RxDoctor Payments Data

Amanda Richardson, PA

Physician Assistant · Floyd, VANPI 1578953303

Payments from drug & device makers

$3,559in general payments, 2019–2025

Across 207 payments — averaging $17.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$568
  • AstraZeneca$456
  • Novo Nordisk$456
  • Lundbeck LLC$271
  • Takeda Pharmaceuticals U.S.A., Inc.$190
  • Amgen$169
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$3,559100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,559 in reported general payments places this provider in the 90th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Medicare billing

Part B allowed, 2024
$325
Medicare patients
14
Services billed
20

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide35$38,133
MounjaroTirzepatide28$27,361
FarxigaDapagliflozin Propanediol28$24,045
JanuviaSitagliptin Phosphate15$22,632
RybelsusSemaglutide15$14,643
JardianceEmpagliflozin17$9,847
VascepaIcosapent Ethyl21$7,265
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,263
Dexlansoprazole DrDexlansoprazole12$1,989
Desvenlafaxine Succinate ErDesvenlafaxine Succinate13$1,314
Albuterol Sulfate HfaAlbuterol Sulfate42$1,099
Lurasidone Hcl13$1,078
Venlafaxine Hcl ErVenlafaxine Hcl43$989
Levothyroxine Sodium133$767
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl14$703

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$456$52,77650 claims
AstraZenecaFarxiga, Breztri Aerosphere$456$31,30840 claims
Lilly USA, LLCMounjaro$23$27,36128 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in Floyd

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →